Enhanced ET-1 signaling is also observed in overweight individuals and is preserved in individuals with obesity suggesting heightened ET-1 signaling precedes the development of obesity and its associated complications in patients with CMS (104). This evidence concerns the gene EDN1 and obesity due to melanocortin 4 receptor deficiency.